Inhibition of histone deacetylases preserves myocardial performance and prevents cardiac remodeling through stimulation of endogenous angiomyogenesis

Journal of Pharmacology and Experimental Therapeutics

Volumn 341, Issue 1, 2012, Pages 285-293

  Zhang, Ling ^a   Qin, Xin ^a   Zhao, Yu ^a   Fast, Loren ^b   Zhuang, Shougang ^b   Liu, Paul ^b   Cheng, Guangmao ^c   Zhao, Ting C ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BROWN UNIVERSITY   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; HISTONE DEACETYLASE; PROTEIN KINASE B; TRICHOSTATIN A; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINESIS; DRUG MECHANISM; ENZYME PHOSPHORYLATION; HEART FUNCTION; HEART INFARCTION; HEART INFARCTION PREVENTION; HEART MUSCLE; HEART MUSCLE CELL; HEART PROTECTION; HEART VENTRICLE CONTRACTILITY; IN VIVO STUDY; MALE; MICROVASCULATURE; MOUSE; MUSCLE DEVELOPMENT; MUSCLE REGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SUICIDE SUBSTRATE; THORACOTOMY; TISSUE PRESERVATION;

ANIMALS; HISTONE DEACETYLASE INHIBITORS; HISTONE DEACETYLASES; HYDROXAMIC ACIDS; MALE; MICE; MICE, INBRED ICR; MUSCLE DEVELOPMENT; MYOCARDIAL INFARCTION; MYOCARDIUM; MYOCYTES, CARDIAC; NEOVASCULARIZATION, PHYSIOLOGIC; VENTRICULAR REMODELING;

EID: 84863349101     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.111.189910     Document Type: Article

References (42)

1. Antos CL, McKinsey TA, Dreitz M, Hollingsworth LM, Zhang CL, Schreiber K, Rindt H, Gorczynski RJ, and Olson EN (2003) Dose-dependent blockade to cardiomyocyte hypertrophy by histone deacetylase inhibitors. J Biol Chem 278:28930-28937. (Pubitemid 36935803)
2. Beltrami AP, Barlucchi L, Torella D, Baker M, Limana F, Chimenti S, Kasahara H, Rota M, Musso E, Urbanek K, et al. (2003) Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114:763-776. (Pubitemid 37186770)
3. Chen HP, Denicola M, Qin X, Zhao Y, Zhang L, Long XL, Zhuang S, Liu PY, and Zhao TC (2011) HDAC inhibition promotes cardiogenesis and the survival of embryonic stem cells through proteasome-dependent pathway. J Cell Biochem 112:3246-3255.
4. Chen LF, Fischle W, Verdin E, and Greene WC (2001) Duration of nuclear NF-κB action regulated by reversible acetylation. Science 293:1653-1657. (Pubitemid 32807844)
5. Cheng K, Li TS, Malliaras K, Davis DR, Zhang Y, and Marbán E (2010) Magnetic targeting enhances engraftment and functional benefit of iron-labeled cardiosphere- derived cells in myocardial infarction. Circ Res 106:1570-1581.
6. Cheung P, Allis CD, and Sassone-Corsi P (2000) Signaling to chromatin through histone modifications. Cell 103:263-271.
7. Fischle W, Emiliani S, Hendzel MJ, Nagase T, Nomura N, Voelter W, and Verdin E (1999) A new family of human histone deacetylases related to Saccharomyces cerevisiae HDA1p. J Biol Chem 274:11713-11720.
8. Frederick JR, Fitzpatrick JR 3rd, McCormick RC, Harris DA, Kim AY, Muenzer JR, Marotta N, Smith MJ, Cohen JE, Hiesinger W, et al. (2010) Stromal cell-derived factor-1α activation of tissue-engineered endothelial progenitor cell matrix enhances ventricular function after myocardial infarction by inducing neovasculogenesis. Circulation 122 (11 Suppl): S107-S117.
9. Granger A, Abdullah I, Huebner F, Stout A, Wang T, Huebner T, Epstein JA, and Gruber PJ (2008) Histone deacetylase inhibition reduces myocardial ischemia-reperfusion injury in mice. FASEB J 22:3549-3560.
10. Grozinger CM, Hassig CA, and Schreiber SL (1999) Three proteins define a class of human histone deacetylases related to yeast Hda1p. Proc Natl Acad Sci U S A 96:4868-4873. (Pubitemid 29214503)
11. Haberland M, Montgomery RL, and Olson EN (2009) The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nat Rev Genet 10:32-42.
12. Hansen JC, Tse C, and Wolffe AP (1998) Structure and function of the core histone N-termini: more than meets the eye. Biochemistry 37:17637-17641. (Pubitemid 29023917)
13. Hassig CA, Tong JK, Fleischer TC, Owa T, Grable PG, Ayer DE, and Schreiber SL (1998) A role for histone deacetylase activity in HDAC1-mediated transcriptional repression. Proc Natl Acad Sci U S A 95:3519-3524. (Pubitemid 28173160)
14. Huangfu D, Osafune K, Maehr R, Guo W, Eijkelenboom A, Chen S, Muhlestein W, and Melton DA (2008) Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat Biotechnol 26:1269-1275.
15. Institute of Laboratory Animal Resources (1996) Guide for the Care and Use of Laboratory Animals 7th ed. Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council, Washington, DC.
16. Kee HJ, Sohn IS, Nam KI, Park JE, Qian YR, Yin Z, Ahn Y, Jeong MH, Bang YJ, Kim N, et al. (2006) Inhibition of histone deacetylation blocks cardiac hypertrophy induced by angiotensin II infusion and aortic banding. Circulation 113:51-59. (Pubitemid 43958488)
17. Kong Y, Tannous P, Lu G, Berenji K, Rothermel BA, Olson EN, and Hill JA (2006) Suppression of class I and II histone deacetylases blunts pressure-overload cardiac hypertrophy. Circulation 113:2579-2588. (Pubitemid 43948006)
18. Laugwitz KL, Moretti A, Lam J, Gruber P, Chen Y, Woodard S, Lin LZ, Cai CL, Lu MM, Reth M, et al. (2005) Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages. Nature 433:647-653. (Pubitemid 40282999)
19. Lee TM, Lin MS, and Chang NC (2007) Inhibition of histone deacetylase on ventricular remodeling in infarcted rats. Am J Physiol Heart Circ Physiol 293:H968-H977.
20. Loffredo FS, Steinhauser ML, Gannon J, and Lee RT (2011) Bone marrow-derived cell therapy stimulates endogenous cardiomyocyte progenitors and promotes cardiac repair. Cell Stem Cell 8:389-398.
21. Luger K, Mäder AW, Richmond RK, Sargent DF, and Richmond TJ (1997) Crystal structure of the nucleosome core particle at 2.8 Å resolution. Nature 389:251-260. (Pubitemid 27406632)
22. Mangi AA, Noiseux N, Kong D, He H, Rezvani M, Ingwall JS, and Dzau VJ (2003) Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 9:1195-1201. (Pubitemid 37173705)
23. Matsuura K, Honda A, Nagai T, Fukushima N, Iwanaga K, Tokunaga M, Shimizu T, Okano T, Kasanuki H, Hagiwara N, et al. (2009) Transplantation of cardiac progenitor cells ameliorates cardiac dysfunction after myocardial infarction in mice. J Clin Invest 119:2204-2217.
24. Oh H, Bradfute SB, Gallardo TD, Nakamura T, Gaussin V, Mishina Y, Pocius J, Michael LH, Behringer RR, Garry DJ, et al. (2003) Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc Natl Acad Sci U S A 100:12313-12318. (Pubitemid 37271557)
25. Ren M, Leng Y, Jeong M, Leeds PR, and Chuang DM (2004) Valproic acid reduces brain damage induced by transient focal cerebral ischemia in rats: potential roles of histone deacetylase inhibition and heat shock protein induction. J Neurochem 89:1358-1367. (Pubitemid 38802657)
26. Samant SA, Courson DS, Sundaresan NR, Pillai VB, Tan M, Zhao Y, Shroff SG, Rock RS, and Gupta MP (2011) HDAC3-dependent reversible lysine acetylation of cardiac myosin heavy chain isoforms modulates their enzymatic and motor activity. J Biol Chem 286:5567-5577.
27. Surani MA, Hayashi K, and Hajkova P (2007) Genetic and epigenetic regulators of pluripotency. Cell 128:747-762. (Pubitemid 46273582)
28. Strahl BD and Allis CD (2000) The language of covalent histone modifications. Nature 403:41-45. (Pubitemid 30038513)
29. Tang XL, Rokosh G, Sanganalmath SK, Yuan F, Sato H, Mu J, Dai S, Li C, Chen N, Peng Y, et al. (2010) Intracoronary administration of cardiac progenitor cells alleviates left ventricular dysfunction in rats with a 30-day-old infarction. Circulation 121:293-305.
30. Tseng A, Stabila J, McGonnigal B, Yano N, Yang MJ, Tseng YT, Davol PA, Lum LG, Padbury JF, and Zhao TC (2010) Effect of disruption of Akt-1 of lin(-)c-kit(+) stem cells on myocardial performance in infarcted heart. Cardiovasc Res 87:704-712.
31. Turner BM (2000) Histone acetylation and an epigenetic code. Bioessays 22:836-845.
32. Verdin E, Dequiedt F, and Kasler HG (2003) Class II histone deacetylases: versatile regulators. Trends Genet 19:286-293. (Pubitemid 36507011)
33. Vigushin DM and Coombes RC (2004) Targeted histone deacetylase inhibition for cancer therapy. Curr Cancer Drug Targets 4:205-218. (Pubitemid 38332557)
34. Wang AH, Bertos NR, Vezmar M, Pelletier N, Crosato M, Heng HH, Th'ng J, Han J, and Yang XJ (1999) HDAC4, a human histone deacetylase related to yeast HDA1, is a transcriptional corepressor. Mol Cell Biol 19:7816-7827. (Pubitemid 29493445)
35. Ware CB, Wang L, Mecham BH, Shen L, Nelson AM, Bar M, Lamba DA, Dauphin DS, Buckingham B, Askari B, et al. (2009) Histone deacetylase inhibition elicits an evolutionarily conserved self-renewal program in embryonic stem cells. Cell Stem Cell 4:359-369.
36. Yuan ZL, Guan YJ, Chatterjee D, and Chin YE (2005) Stat3 dimerization regulated by reversible acetylation of a single lysine residue. Science 307:269-273. (Pubitemid 40116244)
37. Zhang LX, Zhao Y, Cheng G, Guo TL, Chin YE, Liu PY, and Zhao TC (2010) Targeted deletion of NF-κB p50 diminishes the cardioprotection of histone deacetylase inhibition. Am J Physiol Heart Circ Physiol 298:H2154-H2163.
38. Zhao T, Parikh P, Bhashyam S, Bolukoglu H, Poornima I, Shen YT, and Shannon RP (2006) Direct effects of glucagon-like peptide-1 on myocardial contractility and glucose uptake in normal and postischemic isolated rat hearts. J Pharmacol Exp Ther 317:1106-1113. (Pubitemid 43764114)
39. Zhao TC and Kukreja RC (2002) Late preconditioning elicited by activation of adenosine A3 receptor in heart: role of NF-κB, iNOS and mitochondrial K(ATP) channel. J Mol Cell Cardiol 34:263-277. (Pubitemid 37162420)
40. Zhao TC, Cheng G, Zhang LX, Tseng YT, and Padbury JF (2007) Inhibition of histone deacetylases triggers pharmacologic preconditioning effects against myocardial ischemic injury. Cardiovasc Res 76:473-481. (Pubitemid 350007465)
41. Zhao TC, Tseng A, Yano N, Tseng Y, Davol PA, Lee RJ, Lum LG, and Padbury JF (2008) Targeting human CD34+ hematopoietic stem cells with anti-CD45 x antimyosin light-chain bispecific antibody preserves cardiac function in myocardial infarction. J Appl Physiol 104:1793-1800.
42. Zhao TC, Zhang LX, Cheng G, and Liu JT (2010) gp-91 mediates histone deacetylase inhibition-induced cardioprotection. Biochim Biophys Acta 1803:872-880.